IAIlham Alifiar

Ilham Alifiar

*This is an algorithmically generated author record based on publicly available information.

Ilham Alifiar has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhancing Public Knowledge of Musculoskeletal Disorders across 12 Subdistricts of Tasikmalaya

    by Yedy Purwandi Sukmawan, Anisa Pebiansyah, Ilham Alifiar

    Background: Musculoskeletal disorders such as hyperuricemia, osteoarthritis, osteoporosis, and rheumatoid arthritis are increase in prevalence, including in Indonesia, yet public understanding of these conditions remains insufficient.Aims: This study aimed to evaluate the effectiveness of pharmacist-led health promotion initiatives in enhancing public knowledge regarding the etiology, symptoms, and pharmacological treatment of these four musculoskeletal conditions.Methods: Utilizing a pre-experimental One-group pretest-posttest design, the research was conducted across twelve subdistricts in Tasikmalaya City and Tasikmalaya Regency. Participants were selected through total sampling, and data were collected using structured questionnaires administered before and after interactive educational sessions. The key success indicators were a post-test score ≥80 and/or a statistically significant difference (p < 0.05).Results: The program engaged 416 participants across four interventions: hyperuricemia/gout (n=140), osteoarthritis (n=110), osteoporosis (n=101), and rheumatoid arthritis (n=65), consisting predominantly of female participants, particularly pre-elderly and elderly housewives. Conclusion: The health education program significantly improved community knowledge concerning musculoskeletal health and medications, which is anticipated to aid in reducing disease prevalence and improving the quality of life for patients in the region.

  • Open Access

    Translation, Adaptation, and Validation of the Barthel Index for Ischemic Stroke Patients in the West Java Population, Indonesia

    by Ilham Alifiar, Dyah Aryani Perwitasari, Lisda Amalia, Indra Gunawan Affandi

    Introduction: Stroke is a major health concern with a high prevalence in the Indonesian population. The high prevalence of this disease indicates the need for monitoring of the extent to which therapy is effective for patients. The Barthel index is a tool to help assess the outcomes of therapy in stroke patients, especially the patient's daily activities. This study aimed to translate, adapt, and validate the Barthel index for stroke patients in the West Java population, Indonesia. Methods: This study was conducted using a cross-sectional design, and data collection was carried out prospectively in July 2024. It included 55 Indonesian post-stroke patients. The questionnaire was analyzed using reliability and validity tests. Results: The internal consistency, as measured by Cronbach’s alpha value, was ≥ 0.896, indicating excellent reliability (p> 0.7). The validity test yielded a p-value of 0.000 (p < 0.05), demonstrating statistical significance. A strong correlation was observed across most items (r = 0.639-0.846), with the exception of item 10, which showed a moderate correlation (r = 0.591). Discussion: The analysis showed that this questionnaire was reliable, and the majority of the questions exhibited a strong to very strong correlation, and only one question had a moderate correlation. Conclusion: Based on these results, it can be concluded that the Barthel index is valid and reliable for use in stroke patients of the West Java population, Indonesia.


  • Open Access

    ANALISIS KEJADIAN STROKE BERULANG PADA PASIEN YANG MENGGUNAKAN ANTIPLATELET DI RS X KOTA TASIKMALAYA

    by Eva Rosanti, Ilham Alifiar

    Stroke merupakan penyakit yang terjadi pada otak dimana terjadi sumbatan pada pembuluh darah otak atau terjadinya pecah pada pembuluh darah otak. Tingginya mortalitas dan morbiditas pada pasien stroke ini membutuhkan perhatian, terutama terhadap potensi kejadian stroke berulang. Penelitian ini bertujuan untuk mengetahui rata-rata kejadian waktu berulang pada stroke iskemik yang menggunakan antiplatelet di RS X Kota Tasikmalaya. Dalam penelitian ini, digunakan metode observasional dengan desain cross-sectional, pengambilan data dilakukan secara retrospektif. Populasi penelitian adalah pasien stroke yang menggunakan antiplatelet aspirin, clopidogrel dan kombinasi aspirin clopidogrel, data diambil pertama kali pasien didiagnosa stroke iskemik dan kejadian kedua kali masuk UGD dengan diagnose yang sama. Data dikumpulkan melalui rekam medis pasien dan dianalisis menggunakan analisis frekuensi dan uji chi-square untuk menentukan hubungan antara penggunaan antiplatelet dan kejadian stroke berulang. Hasil penelitian menunjukan bahwa rata rata terjadinya stroke berulang pada pengguna aspirin tunggal adalah 71,66 hari, pada pengguna clopidogrel tunggal adalah 49,94 hari dan pada penguna kombinasi adalah 140,16 hari. Dari penelitian yang dilakukan, pemilihan penggunaan antiplatelet berpengaruh terhadap rata-rata waktu kejadian stroke iskemik berulang.


  • Open Access

    ANALISIS KEJADIAN STROKE BERULANG PADA PASIEN YANG MENGGUNAKAN ANTIPLATELET DI RUMAH SAKIT X CIAMIS

    by Seisa Wisastry, Ilham Alifiar, Citra Dewi Salasanti

    Stroke is an acute and focal neurological deficit syndrome, which is clinically defined as the result of blood vessel injury in the central nervous system caused by rupture and blockage of blood vessels to the brain which results in reduced energy and the brain lacking nutrition. The aim of the study was to analyze the incidence of recurrent stroke in patients using antiplatelet drugs single aspirin, single clopidogrel and the combination at Hospital primary data obtained from the patient's medical record. Data and frequencies collected through patient medical records were analyzed using the chi-square test to determine the relationship between antiplatelet use and recurrent stroke. The results of this study showed that the number of stroke patients was 368 and recurrent stroke was 32 patients with an average duration of stroke recurrence, namely single aspirin 127.86 days, single clopidogrel 77 days, and the combination 237.39 days. From the data obtained, it can be concluded that Antiplatelet administration can affect the time to recurrent stroke. Keywords: Stroke, Antiplatelet, Aspirin, Clopidogrel, Combination

  • Open Access

    Utility analysis of outpatient hypertensive patients with and without comorbidities using the EQ-5D-5L instrument: A study at UPTD Puskesmas Pagerageung, Tasikmalaya Regency, West Java

    by Muharam Priatna, Putri Salma Maulida, Ilham Alifiar

    Hypertension is a chronic condition often requiring lifelong treatment, which can impact patients’ quality of life (QoL) in physical, psychological, and social domains. The presence of comorbid conditions alongside hypertension can further deteriorate QoL. Health utility measurement, particularly in hypertensive patients with comorbidities, is crucial for understanding these compounded effects. This study aims to evaluate and compare the quality of life utility in hypertensive patients with and without comorbidities using the EQ-5D-5L instrument, focusing on how comorbid conditions influence overall QoL. A descriptive observational study with a cross-sectional design was conducted among 100 hypertensive patients treated at UPTD Puskesmas Pagerageung, Tasikmalaya, from January to March 2024. Participants were selected through purposive sampling. The EQ-5D-5L questionnaire was used to assess utility scores, which were calculated using an Indonesian-specific value set. Chi-square and Post Hoc LSD analyses were applied to explore relationships between utility scores and demographic factors such as age, gender, and occupation. The average utility score for hypertensive patients without comorbidities was 0.669, higher than that of patients with comorbid conditions. Specifically, patients with diabetes mellitus, osteoarthritis, gastric conditions, heart disease, and severe comorbidities (e.g., kidney disease, cataracts, stroke) had average scores of 0.578, 0.640, 0.651, 0.537, and 0.148, respectively. Age was significantly associated with utility scores (p = 0.014), whereas gender and occupation showed no significant impact. Hypertensive patients without comorbidities had a better quality of life utility than those with additional health issues. Targeted management of comorbidities is essential to improve the quality of life among hypertensive patients, especially in those facing compounded health challenges.


  • Open Access

    Konseling Informasi Beserta Pentingnya Kepatuhan Dalam Penggunaan Anti Hipertensi Pada Penderita Hipertensi Sekunder

    by Ilham Alifiar, Suci Mega Rahmi, Fatimah Azahra, Ratu Aulia, Nadya Dwiputri, Rifki Permana Agung

    Pendahuluan: Hipertensi merupakan kondisi peningkatan tekanan darah ≥140 mmHg (sistolik) dan/atau ≥90 mmHg (diastolik) yang menjadi penyakit berbahaya yang tidak dapat disembuhkan. Kepatuhan minum obat menjadi faktor penting yang juga menjadi permasalahan ketidakefektifan terapi pada hipertensi. Pengetahuan menjadi faktor pengaruh ketidakpatuhan terapi yang akan menjadi intervensi utama dalam penelitian. Tujuan: Penelitian bertujuan meningkatkan pemahaman masyarakat Desa Cilumba Kecamatan Cikatomas tentang informasi penggunaan serta kepatuhan meminum obat obat hipertensi dengan mengukur parameter pengetahuan Metode: Penelitian menggunakan metode konseling, diskusi dan tanya jawa . Intervensi yang diberikan terhadap responden penelitian yaitu konseling informasi penggunaan obat hipertensi serta pentingnya kepatuhan meminnum obat. Hasil: Responden penelitian didapati sejumlah 20 orang yang didominasi oleh perempuan dengan persentase 55% dibandingkan laki-laki dengan persentase 45%. Usia responden didominasi oleh usia lansia dengan rentang usia 46-57 tahun dengan persentase 65% dibandingkan usia dewasa dengan rentang usia 20-45 tahun dengan persentase 35%. Profil pendidikan responden didominasi oleh tamatan SD dengan persentase sebesar 85% jika dibandingkan dengan tamatan SD, SMP, SMA, S1 dengan persentase masing-masing 5%. Berdasarkan hasil intervensi konseling, keseluruhan parameter pengetahuan yang diukur mencakup cara penggunaan, dosis pemakaian, cara penyimpanan, interaksi obat, efek samping, lama penggunaan, dan cara membuang meningkat setelah diberikan intervensi konseling. Peningkatan cara penggunaan dari 35% menjadi 95%; dosis pemakaian dari 55% menjadi 100%; cara penyimpanan dari 70% menjadi 100%; interaksi obat dari 20% menjadi 85%; efek samping dari 5% menjadi 85%; lama penggunaan dari 0% menjadi 80%; dan cara membuang dari 0% menjadi 95%. Kesimpulan: Konseling informasi mengenai penggunaan terapi antihipertensi terhadap 20 responden penelitian efektif meningkatkan pengetahuan responden mengenai terapi antihipertensi

  • Open Access

    Studi Farmakovigilans Obat Golongan Antipsikotik Pada Pasien Skizofrenia Di Rsud SMC Kabupaten Tasikmalaya

    by Siti Salma Salsabila, Ilham Alifiar, Lilis Tuslinah

    Pendahuluan: Skizofrenia adalah salah satu jenis penyakit gangguan jiwa disertai beberapa gejala diantaranya halusinasi, delusi, gangguan proses berpikir dan prilaku aneh. Tujuan: Penelitian ini bertujuan mengetahui jenis obat golongan antipsikotik yang sering digunakan, evaluasi obat yang mencakup penilaian, pemahaman juga pencegahan efek samping obat juga gejala dan efek samping setelah mengkonsumsi obat golongan antipsiotik pada pasien skizofrenia di RSUD SMC Kabupaten Tasikmalaya Metode: Jenis penelitian ysng digunakan ialah observasional dengan desain penelitian cross sectional dan pengambilan data dilakukan secara prospektif. Hasil: Hasil penelitian menunjukan bahwa penggunaan obat golongan antipsikotik yang paling banyak ialah kombinasi dengan obat jenis lain sebanyak 60 orang dan penggunaan obat golongan antipsikotik kedua (atipikal) tunggal sebanyak 20 orang clozapine 85% dan risperidone 15%. Gejala yang palng banyak pada pasien skizofrenia gejala positif 71% dan negatif 29%, efek samping yang sering muncul yakni sedasi 32%. Evaluasi obat berdasarkan ketepatan indikasi dan dosis 100% Kesimpulan: Hasil analisis menunjukan semua hasil data demografi tidak terdapat hubungan dengan efek samping obat yang muncul, efek samping obat mayoritas disebabkan oleh obat itu sendiri

  • Open Access

    Gambaran Nutrisi Parenteral Pada Pasien Intensive Care Unit di Salah Satu Rumah Sakit di Kota Tasikmalaya

    by Erma Nur Alpiana, Ilham Alifiar, Fajar Setiawan

    Background: Nutrition refers to the intake of food that is beneficial for maintaining good health. Parenteral nutrition refers to the intravenous administration of substances such as carbohydrates, proteins, lipids, and electrolytes. Attaining optimal nutrition relies on exact utilization, while imprecise utilization leads to malnutrition. Objective: This study was conducted to evaluate the administration of parenteral nutrition in patients who were hospitalized in ICU of X Hospital in Tasikmalaya City and to know the relationship between the accuracy of parenteral nutrition and the factors that affect it. Method: This study is an observational one, employing a cross-sectional research design and prospectively collecting data. Data was gathered between the months of February and April in the year 2020. The acquired data is subsequently examined with SPSS, specifically employing the Chi-square test. Results: The research included a total of 23 patients who satisfied the specified criteria. These patients varied in terms of age, duration of care, nutrient intake, clinical symptoms, drug usage, and nutritional state upon admission to the ICU. The parenteral nutrition administered to patients includes Kabiven, Aminofluid, KA-EN 3B, D5%, D10%, and Hydromal. Out of the entire number of patients, only 2 achieved the required daily amount of total parenteral nutrition during therapy, whereas 21 patients fell short of meeting the minimal criterion of total daily parenteral nutrition. Conclusion: The study data reveals that certain patients have fulfilled the criteria for minimal total nutritional therapy, while others have not met the daily minimum nutritional requirements. Keywords: ICU, parenteral nutrition, accuracy of parenteral nutrition Intisari Latar belakang: Nutrisi adalah makanan yang berguna bagi kesehatan. Nutrisi parenteral adalah zat makro maupun mikro yang dibutuhkan tubuh namun diberikan secara intravena. Nutrisi yang tepat akan membantu proses penyembuhan pasien, dan sebaliknya nutrisi yang kurang optimal dapat menghambat proses penyembuhan pasien. Tujuan: Penelitian ini dilakukan untuk mengevaluasi pemberian nutrisi parenteral pada pasien yang di rawat di ruang ICU salah satu rumah sakit di Kota Tasikmalaya. Metode: Penelitian ini merupakan penelitian observasional dengan desain penelitian yang digunakan adalah cross-sectional dan pengambilan data dilakukan secara prospektif. Sampel dalam penelitian ini adalah semua pasien yang dirawat di ICU yang diambil menggunakan teknik consecutive sampling. Data dikumpulkan mulai Februari sampai April tahun 2020. Data yang didapatkan kemudian dianalisis menggunakan SPSS yaitu uji Chi-square. Hasil: Subjek penelitian yang memenuhi kriteria inklusi sebanyak 23 pasien dengan berbagai macam usia, lama rawat, asupan nutrisi, manifestasi klinis, pemberian obat dan status nutrisi saat masuk ICU. Nutrisi parenteral yang digunakan pada pasien yaitu Kabiven®, Aminofluid, KA-EN 3B, D5%, D10% dan Hydromal. Sebanyak 2 pasien memenuhi standar minimal nutrisi parenteral total harian selama dirawat, dan 21 pasien belum memenuhi standar minimal jumlah nutrisi parenteral total hariannya. Kesimpulan: Pemberian nutrisi parenteral pada pasien ICU RS X kota Tasikmalaya belum tepat dalam memenuhi kebutuhan nutrisi pasien, karena hanya 2 pasien yang sudah memenuhi syarat minimal terapi nutrisi total, namun terdapat 21 pasien yang masih belum memenuhi standar minimal nutrisi yang harus dipenuhi setiap hari sedangkan hasil uji statistik dengan menggunakan Chi-Square diperoleh hasil yang menunjukkan tidak terdapat hubungan yang signifikan antara data demografi pasien dengan ketepatan pemberian nutrisi parenteral. Kata kunci: ICU, nutrisi parenteral, ketepatan pemberian nutrisi parenteral


  • Open Access

    The ANALYSIS OF ACTUAL DRUG INTERACTIONS IN THE TREATMENT OF INPATIBLE GASTRITIS PATIENTS AT RSUD X

    by Nadila Oktaviani, Ilham Alifiar, Dichy Nuryadin Zain

    Gastritis is a health problem with a high prevalence in society. Gastritis is a digestive tract disorder that has problems with damage to the gastric mucosa. Drug interaction events occur when the effect of a drug changes due to the presence of another drug. The purpose of this study was to describe the actual incidence of drug interactions in the treatment of inpatients with gastritis at RSUD X. This research was conducted at RSUD X as an observational study with a cross-sectional study design which was carried out prospectively while the patient was undergoing treatment at the hospital during the period January-April 2023. The sample was collected using a consecutive sampling technique and a total of 64 patients who met the inclusion criteria were obtained. The research results obtained from 22 cases of potential drug interactions found actual drug interaction events in the drug combination between Potassium Chloride (KSR) and Hyoscyamine which provides a synergistic or additive pharmacodynamic interaction because it can benefit patients with increased potassium levels from the therapy. Keywords: Gastritis, Aktual Drug Interaction

  • Open Access

    Analisis Kesesuaian Dosis Obat Pada Pasien Gagal Ginjal Berdasarkan Perhitungan Klirens Kreatinin Di Rumah Sakit X

    by Syifa Auliya Nur Hidayat, Ilham Alifiar, Citra Dewi Salasanti

    Patients with renal impairment have different pharmacokinetic parameters from those with normal renal function. Therefore, with kidney function that is no longer normal, administering appropriate and appropriate drugs to patients with kidney failure is important to avoid adverse drug reactions and achieve optimal drug therapy. This research aims toanalyzed drugs requiring dose adjustment in patients with kidney failure based on creatinine clearance calculations with the Cockroft Gault formula, Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) and Modification of Diet in Renal Disease (MDRD). The study was conducted using a cross-sectional method with prospective data collection by tracing data from the medical records of kidney failure patients for the period January-April 2023. Next, creatinine clearance was calculated and the dose suitability was assessed in reference to Renal Pharmacotherapy 2nd edition in 2021 and The Renal Drug Handbook 5th edition 2019. Data analysis was carried out descriptively and the Chi-Square test with SPSS to see the effect of the suitability of the dose with the formula used. The number of patients who met the inclusion criteria was 68 patients. Of the 213 drugs prescribed, 210 drugs (98.60%) were dosed correctly and 3 drugs (1.40%) were not dosed correctly. Drugs that were not properly dosed were allopurinol, ketorolac injection, and codeine. The results of the Chi-Square showed no significant difference in the suitability of the dose with the Cockroft Gault formula, Chronic Kidney Disease Epidemiology Collaboration (CKD EPI), and Modification of Diet in Renal Disease (MDRD) formulas (p = 1.000). Keywords: Renal Failure, Creatinine Clearance, Dosage Adjusment